Fuad El Rassi, MD

Role

Hematology
Specialty

Blood Disorders
Research Program

Discovery and Developmental Therapeutics
Practicing Since

2014

Request Appointment

Titles & Roles

Associate Professor, Department of Hematology and Medical Oncology

Emory University School of Medicine
Director of Sickle Cell Research, Georgia Comprehensive Sickle Cell Program

Grady Health System

Education & Training

Education

Fellowship, Hematology & Oncology, 2014
Emory University School of Medicine
Residency, Internal Medicine, 2011
Saint Louis University School of Medicine
Medical Education, , 2006
American Univeristy of Beirut

Board Certifications

Hematology
American Board of Internal Medicine, 2014
Internal Medicine
American Board of Internal Medicine, 2011

Professional Memberships

American Society of Hematology
Sickle Cell Adult Provider Network
Sickle Cell Disease Foundation Research
American Society of Clinical Oncology

Title/Journal	Authors	Publication Date
Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1-2 trial. The Lancet. Haematology	MT Gladwin, VR Gordeuk, PC Desai, C Minniti, EM Novelli, CR Morris, KI Ataga, L De Castro, SA Curtis, F El Rassi, HJ Ford, T Harrington, ES Klings, S Lanzkron, D Liles, J Little, A Nero, W Smith, JG Taylor, A Baptiste, W Hagar, J Kanter, A Kinzie, T Martin, A Rafique, MJ Telen, CM Lalama, GJ Kato, KZ Abebe	01/05/2024
Enhanced IgG immune response to COVID-19 vaccination in patients with sickle cell disease. British journal of haematology	H Nakahara, N Cheedarla, HP Verkerke, S Cheedarla, SC Wu, JE Hendrickson, A Chang, ML McLemore, F El Rassi, JD Roback, AS Neish, RM Fasano, SR Stowell	01/09/2023
Presentations and outcomes among sickle cell disease patients with COVID-19 at a large southern healthcare system. Expert review of hematology	K Clarke, YM Shin, MAK Hall, M Moussa, M McLemore, F El Rassi	01/02/2023
A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis. Blood	CD Dampier, MJ Telen, T Wun, RC Brown, P Desai, F El Rassi, B Fuh, J Kanter, Y Pastore, J Rothman, JG Taylor, D Readett, KM Sivamurthy, B Tammara, LJ Tseng, JN Lozier, H Thackray, JL Magnani, KL Hassell	12/01/2023
Burden of disease, treatment utilization, and the impact on education and employment in patients with sickle cell disease: A comparative analysis of high- and low- to middle-income countries for the international Sickle Cell World Assessment Survey. American journal of hematology	I Osunkwo, J James, F El-Rassi, A Nero, CP Minniti, C Trimnell, J Paulose, N Ramscar, T Bailey, O Rajkovic-Hooley, B Andemariam	01/08/2022
Sickle Cell Disease and Kidney. Advances in chronic kidney disease	P Amarapurkar, L Roberts, J Navarrete, F El Rassi	01/03/2022
Catastrophic Neurological Complications in 2 Patients With Sickle Cell Disease and COVID-19. Journal of investigative medicine high impact case reports	K Clarke, K Benameur, Z Wiley, YM Shin, M Moussa, F El Rassi, M McLemore	01/01/2022
Impact of sickle cell disease on patients' daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey (SWAY). American journal of hematology	I Osunkwo, B Andemariam, CP Minniti, BPD Inusa, F El Rassi, B Francis-Gibson, A Nero, C Trimnell, MR Abboud, JB Arlet, R Colombatti, M de Montalembert, S Jain, W Jastaniah, E Nur, M Pita, L DeBonnett, N Ramscar, T Bailey, O Rajkovic-Hooley, J James	01/04/2021
Outcomes of Chronic Phase Chronic Myeloid Leukemia after Treatment with Multiple Tyrosine Kinase Inhibitors. Journal of clinical medicine	JH Kong, EF Winton, LT Heffner, M Gaddh, B Hill, J Neely, A Hatcher, M Joseph, M Arellano, F El-Rassi, A Kim, JH Khoury, VK Kota	20/05/2020
Challenges in the treatment and prevention of delayed hemolytic transfusion reactions with hyperhemolysis in sickle cell disease patients. Transfusion	CL Dean, CL Maier, S Chonat, A Chang, MA Carden, F El Rassi, ML McLemore, SR Stowell, RM Fasano	01/05/2019
Extreme hyperbilirubinemia: An indicator of morbidity and mortality in sickle cell disease. World journal of hepatology	JP Haydek, C Taborda, R Shah, PA Reshamwala, ML McLemore, FE Rassi, S Chawla	27/03/2019
Iron overload in patients with myelodysplastic syndromes: An updated overview. Cancer	NM Moukalled, FA El Rassi, SN Temraz, AT Taher	15/10/2018

Awards

Honors, American University of Beirut Medical School, 2004
Nominated for the Penrose Award, American University of Beirut Medical School, 2006
Excellence in Student Teaching Award, Saint Louis University Hospital, Saint Louis, MO, 2011
Honoree of the Emory School of Medicine Doctors’ Day Recognition, Emory University School of Medicine, 2019

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.